KDM6A and plasma cell myeloma: In addition to DLBCL, a subset of multiple myeloma (MM) tumors display globally elevated H3K27me3 levels due to either inactivation of H3K27 demethylases (UTX/KDM6A) or overexpression of PHF1955,56.